CD81 is an entry coreceptor for hepatitis C virus.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2004-05-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.0402253101PMID 15123813PMCID PMC409908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

  2003cited by this paper
• Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes

  2003cited by this paper
• L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus

  2003cited by this paper
• Establishment of B-Cell Lymphoma Cell Lines Persistently Infected with Hepatitis C Virus In Vivo and In Vitro: the Apoptotic Effects of Virus Infection

  2003cited by this paper
• Expressionof Unmodified Hepatitis C Virus Envelope Glycoprotein-Coding SequencesLeads to Cryptic Intron Excision and Cell Surface Expression of E1/E2Heterodimers Comprising Full-Length and Partially DeletedE1

  2003cited by this paper
• Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins

  2003cited by this paper
• Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor*

  2003cited by this paper
• Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR

  2003cited by this paper
• The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

  2002cited by this paper
• Genetic diversity and models of viral evolution for the hepatitis C virus.

  2002cited by this paper
• Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro

  2002cited by this paper
• Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies.

  2002cited by this paper
• Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver.

  2001cited by this paper
• In search of hepatitis C virus receptor(s).

  2001cited by this paper
• Identification of Amino Acid Residues in CD81 Critical for Interaction with Hepatitis C Virus Envelope Glycoprotein E2

  2000cited by this paper
• Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus

  2000cited by this paper
• Structure-Function Analysis of Hepatitis C Virus Envelope-CD81 Binding

  2000cited by this paper
• Nucleotide and Amino Acid Complexity of Hepatitis C Virus Quasispecies in Serum and Liver

  2000cited by this paper
• Clinical Significance of Hepatitis C Virus Genotypes

  2000cited by this paper
• Uneven Distribution of Hepatitis C Virus Quasispecies in Tissues from Subjects with End-Stage Liver Disease: Confounding Effect of Viral Adsorption and Mounting Evidence for the Presence of Low-Level Extrahepatic Replication

  2000cited by this paper
• Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.

  1999cited by this paper
• Functional Analysis of Cell Surface-Expressed Hepatitis C Virus E2 Glycoprotein

  1999cited by this paper
• Analysis of a successful immune response against hepatitis C virus.

  1999cited by this paper
• Nonrandom Distribution of Hepatitis C Virus Quasispecies in Plasma and Peripheral Blood Mononuclear Cell Subsets

  1999cited by this paper
• CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system.

  1998cited by this paper
• Binding of hepatitis C virus to CD81.

  1998cited by this paper
• In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus.

  1998cited by this paper
• Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus.

  1998cited by this paper
• Detection of virus-like particles in liver biopsies from HCV-infected patients.

  1998cited by this paper
• Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry

  1998cited by this paper
• Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro

  1997cited by this paper
• Long-term primary cultures of adult human hepatocytes.

  1997cited by this paper
• Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.

  1997cited by this paper
• Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG

  1995cited by this paper
• Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.

  1995cited by this paper
• Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection.

  1995cited by this paper
• Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses

  1994cited by this paper
• Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line.

  1992cited by this paper

• Ex vivo culture models to study viral infections of the liver.

  2025cites this paper
• The Exosome-Mediated Epigenome: Non-Coding RNA and mRNA-Coding Networks in Microbiome–Cellular Communication, Inflammation, and Tumorigenesis Along the Oral–Gut–Lung Axis

  2025cites this paper
• CD81 is a receptor for equine arteritis virus (family: Arteriviridae)

  2025cites this paper
• Immune Checkpoints and the Immunology of Liver Fibrosis

  2025cites this paper
• CD81 fusion alters SARS-CoV-2 Spike trafficking

  2024cites this paper
• Superresolution Imaging Reveals the Spatial Organization of CD81 Microdomains in Regulating Membrane Signaling on Jurkat T Cell Microvilli

  2024cites this paper
• The conformational dynamics of Hepatitis C Virus E2 glycoprotein with the increasing number of N-glycosylation unraveled by molecular dynamics simulations

  2024cites this paper
• CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells

  2024cites this paper
• Tetraspanins: structure, dynamics, and principles of partner-protein recognition.

  2023cites this paper
• The matrix metalloproteinase ADAM10 supports hepatitis C virus entry and cell-to-cell spread via its sheddase activity

  2023cites this paper
• Application of exosome engineering modification in targeted delivery of therapeutic drugs.

  2023cites this paper
• A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus

  2023cites this paper
• Multiscale network analysis identifies potential receptors for SARS‐CoV‐2 and reveals their tissue‐specific and age‐dependent expression

  2023cites this paper
• Occludin stalls HCV particle dynamics apart from hepatocyte tight junctions, promoting virion internalization

  2022cites this paper
• Mesenchymal Stem Cell-Derived Extracellular Vesicles in Liver Immunity and Therapy

  2022cites this paper
• An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development

  2021cites this paper
• Ceramide 24 Level in Hepatitis C Virus- Patients and Healthy Persons

  2021cites this paper
• Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects

  2021cites this paper
• Tumor-Derived Extracellular Vesicles and the Immune System—Lessons From Immune-Competent Mouse-Tumor Models

  2020cites this paper
• Identification of interferon receptor IFNAR2 as a novel HCV entry factor by using chemical probes.

  2020cites this paper
• Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus

  2019cites this paper
• Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine

  2019cites this paper
• Characterization of functional determinants in the C-terminal part of hepatitis C virus E1 glycoprotein ectodomain

  2019influential citation
• Identification of novel targets in fibrosis

  2018cites this paper
• Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp).

  2018cites this paper
• Defining Breadth of Hepatitis C Virus Neutralization

  2018cites this paper
• Liver sinusoidal endothelial cells — gatekeepers of hepatic immunity

  2018cites this paper
• Current status and future development of infectious cell‐culture models for the major genotypes of hepatitis C virus: Essential tools in testing of antivirals and emerging vaccine strategies

  2018cites this paper
• Regulated Entry of Hepatitis C Virus into Hepatocytes

  2017cites this paper
• Etude fonctionnelle et structurale de protéines impliquées dans l'invasion des cellules hépatocytaires par les sporozoïtes de Plasmodium

  2017cites this paper
• STUDY OF INNATE IMMUNITY AND THE EFFECT OF IVIG INFUSIONS IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY AND X-LINKED AGAMMAGLOBULINEMIA PhD COURSE IN IMMUNOLOGICAL, HAEMATOLOGICAL AND RHEUMATOLOGICAL SCIENCES CLINICAL IMMUNOLOGY XXIX CYCLE

  2017influential citation
• CD19, from bench to bedside.

  2017cites this paper
• Extrahepatic Replication of HCV

  2016cites this paper
• HCV Receptors and Virus Entry

  2016cites this paper
• Experimental models of hepatitis B and C — new insights and progress

  2016cites this paper
• Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles.

  2016cites this paper
• Plasmodium meets AAV—the (un)likely marriage of parasitology and virology, and how to make the match

  2016cites this paper
• Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.

  2016cites this paper
• Molecular Events of Hepatitis C in Hepatocellular Carcinoma

  2016cites this paper
• DETERMINANTS OF NEUTRALIZATION IN ENVELOPE PROTEINS OF HEPATITIS C VIRUS

  2016cites this paper
• Hepatitis C Virus-Host Interactions

  2016cites this paper
• Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer

  2016cites this paper
• Comparative Proteomics Reveals Important Viral-Host Interactions in HCV-Infected Human Liver Cells

  2016cites this paper
• Claudins and pathogenesis of viral infection.

  2015cites this paper
• A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway

  2015cites this paper
• Recognition of hepatitis C virus RNA by toll like receptors 7 and 8 : implications for the initiation of innate immune response

  2015cites this paper
• Molecular Mechanisms of Hepatitis C Virus Entry – Impact of Host Cell Factors for Initiation of Viral Infection

  2015cites this paper
• TnBP⁄Triton X-45 Treatment of Plasma for Transfusion Efficiently Inactivates Hepatitis C Virus

  2015cites this paper
• Successful disabling of the 5' UTR of HCV using adeno-associated viral vectors to deliver artificial primary microrna mimics

  2015influential citation
• Hepatitis regulation by the inflammasome signaling pathway

  2015cites this paper
• Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.

  2015cites this paper
• The missing pieces of the HCV entry puzzle.

  2015cites this paper
• Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses.

  2015cites this paper
• The role of stromal cells in Hepatitis C virus infection

  2015cites this paper
• Retroviral Pseudotypes – From Scientific Tools to Clinical Utility

  2015cites this paper
• Resistance to hepatitis C virus: potential genetic and immunological determinants.

  2015cites this paper
• Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry

  2014influential citation
• Analysis of the role of p7 protein function in hepatitis C virus life cycle

  2014cites this paper
• Protein phosphatase 2 A inhibits interferon signaling through the Jak STAT pathway and promotes hepatitis C viral replication

  2014cites this paper
• Recent advances in HCV entry

  2014cites this paper
• Functional Characterization of Nuclear Localization and Export Signals in Hepatitis C Virus Proteins and Their Role in the Membranous Web

  2014cites this paper
• High resolution microscopy studies of the architecture of sites of hepatitis C virus RNA replication

  2014cites this paper
• CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies

  2014cites this paper
• Investigating mechanisms of Hepatitis C virus endocytosis

  2014cites this paper
• Structural characterization of viral envelope glycoproteins

  2014cites this paper
• Protein phosphatase 2A inhibits interferon signaling through the Jak STAT pathway and promotes hepatitis C viral replication

  2014cites this paper
• CD81 and Hepatitis C Virus (HCV) Infection

  2014cites this paper
• A Small-Molecule Inhibitor of Hepatitis C Virus Infectivity

  2013cites this paper
• Heterogeneity and New Epitopes of Hepatitis C Virus Genotype 4

  2013cites this paper
• Tetraspanins

  2013cites this paper
• Hepatic stellate cells, liver innate immunity, and hepatitis C virus

  2013cites this paper
• The Role of NS3 Helicase Domain in Hepatitis C Virus Particle Assembly

  2013cites this paper
• A novel helper-dependent adenovirus-based cell culture model for Hepatitis C virus replication and production

  2013cites this paper
• Hepatitis C Virus E1E2 co-evolving networks unveil their functional dialogs and highlight original therapeutic strategies

  2013cites this paper
• Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease.

  2013cites this paper
• Mechanism of hepatic inflammation during hepatitis C virus infection

  2013cites this paper
• Binding of HCV to its receptor leads to fusion between the virion envelope and the cell membrane, and release of the viral RNA into the cytoplasm of the host cell (Fig- ure 2). The genome serves as a messenger

  2013cites this paper
• Evolution of Cell Culture Systems for HCV

  2013cites this paper
• Attachment factors.

  2013cites this paper
• Hypervariable Region 1 Deletion and Required Adaptive Envelope Mutations Confer Decreased Dependency on Scavenger Receptor Class B Type I and Low-Density Lipoprotein Receptor for Hepatitis C Virus

  2013cites this paper
• Cross-linking of CD81 by HCV-E2 protein inhibits human intrahepatic plasmacytoid dendritic cells response to CpG-ODN.

  2013cites this paper
• Development of FRET-based assays to characterize the HCV NS5a homodimerization and its interaction with RNA

  2013cites this paper
• Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle.

  2013cites this paper
• The Molecular Basis of Antibody Mediated Neutralization of Hepatitis C Virus

  2013cites this paper
• Temporal Analysis of Hepatitis C Virus Cell Entry with Occludin Directed Blocking Antibodies

  2013cites this paper
• Differential Expression of Candidate Virus Receptors in Human T Lymphocytes Prone or Resistant to Infection with Patient-Derived Hepatitis C Virus

  2013cites this paper
• Monoclonal Antibodies against Hepatitis C Genotype 3a Virus Like Particle Inhibit Virus Entry in Cell Culture System

  2013cites this paper
• Hepatitis C Viral Entry Inhibitors Prolong Viral Suppression by Replication Inhibitors in Persistently-Infected Huh7 Cultures

  2013cites this paper
• Determinants in the pandemic H3N2 influenza A virus hemagglutinin that affect receptor binding and transmission in the pig

  2013cites this paper
• Dependency on Scavenger Receptor Class B Type I and Low Density Lipoprotein Receptor for 3

  2013cites this paper
• Functional characterisation of natural variants of the hepatitis C virus p7 ion channel protein

  2013cites this paper
• Hepatitis C virus: standard-of-care treatment.

  2013cites this paper
• The Role of CD81 in HCV and Plasmodium Infection

  2013cites this paper
• Polymorfismus -3176C/T genu pro interleukin 28B při léčbě virové hepatitidy C

  2013cites this paper
• PROGRAMA DE PÓS-GRADUAÇÃO EM PESQUISA E DESENVOLVIMENTO - BIOTECNOLOGIA MÉDICA MESTRADO PROFISSIONAL

  2013cites this paper
• Lymphotropism of Hepatitis C Virus

  2012cites this paper
• Investigating virus entry using cell-culture adapted hepatitis C virus

  2012cites this paper
• Strategies for Targeting Tetraspanin Proteins

  2012influential citation
• Hepatitis C Virus Attachment Mediated by Apolipoprotein E Binding to Cell Surface Heparan Sulfate

  2012cites this paper
• A human claudin‐1–derived peptide inhibits hepatitis C virus entry

  2012cites this paper